- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT05590130
Comparación de dos objetivos de oxigenación con dos oxímetros diferentes: impacto en las tasas de flujo de oxígeno y la oxigenación (Oxygap pong)
The investigators recently evaluated 4 different oximeters among the most commonly used with arterial catheter in place and compared SpO2 with SaO2 obtained on arterial gas. Correlations between SaO2 and SpO2 were poor for all oximeters, as previously known, and SpO2-SaO2 bias were different between oximeters. Some oximeters (Masimo, Nellcor) had lower biases but they detected less well hypoxemia. Some oximeters underestimated SaO2 (Nonin) but detected very well hypoxemia, and some overestimated SaO2 (Philips). The investigators concluded that oximeters provide different informations to clinicians, and oxygenation targets should take into account for these differences.
The assumption is that the SpO2 target AND oximeter used will both have an impact on oxygen flows and that these effects will add up. With a high SpO2 target, oxygen flows will be significantly greater and with the Nonin oximeter, the required flows will be greater than with the Philips oximeter.
NB: the results obtained were in a population with light skin pigmentation (96% of the patients were Fitzpatrick 1-2, reflecting the local hospitalized population).
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
- Dispositivo: Manual oxygen titration with Nonin oximeter (SpO2 target 90%)
- Dispositivo: Manual Oxygen titration with Philips oximeter (SpO2 target 90%)
- Dispositivo: Manual oxygen titration with Nonin oximeter (SpO2 target 94%)
- Dispositivo: Manual Oxygen titration with Philips oximeter (SpO2 target 94%)
Descripción detallada
The oximeters to be evaluated will be the Nonin (Plymouth, MN), and the Philips (Eindhoven, Netherlands). The sensors used will be digital reusable sensors for all oximeters. Because of the impact of the fingers used for SpO2 measurement, each oximeter will be randomly assigned a different finger to each patient (digit 2 and 3 on the hand opposite to the arterial catheter).
Two SpO2 targets will be assessed: 90% and 94%. A total of four 10-minute periods will be performed in randomized order: Nonin 90, Nonin 94, Philips 90, and Philips 94.
At the end of each 10-minute period, arterial gas will be collected through the arterial catheter.
The adjustment of the oxygen flow rates will be performed manually. The average oxygen flow of the last 2 minutes of the period will be considered.
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Francois Lellouche
- Número de teléfono: 3572 418656-8711
- Correo electrónico: francois.lellouche@criucpq.ulaval.ca
Copia de seguridad de contactos de estudio
- Nombre: Pierre Alexandre Bouchard
- Número de teléfono: 2712 418656-8711
- Correo electrónico: pierre-alexandre.bouchard@criucpq.ulaval.ca
Ubicaciones de estudio
-
-
Quebec
-
Québec, Quebec, Canadá, G1V4G5
- Reclutamiento
- Institut Universitaire de Cardiologie et de Pneumologie de Québec
-
Contacto:
- Francois Lellouche
- Correo electrónico: francois.lellouche@criucpq.ulaval.ca
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- ≥ 18 years of age
- Patients admitted to postoperative cardiac surgery intensive care unit
- Presence of an arterial catheter Specific for the extubate patient
- Ongoing on conventional oxygen therapy at moderate flow (up to a maximum of 5L/min) with SpO2 between 88 and 100% with the usual oximeter and nasal cannula.
- SpO2 < 92% ambient air Specific for the intubate patient FiO2 <= 0.60 with SpO2 between 88 and 100% with usual oximeter SpO2 < 92% with FiO2 0.21
Exclusion Criteria:
- No SpO2 signal with oximeter in use
- False nails or nail polish
- Methemoglobinemia >0.015 on last available arterial gas
- Patient in isolation (multi-resistant bacteria, C-Difficile, SARS-CoV-2 ...) Specific for the extubate patient
- Expected to use another respiratory support within one hour of inclusion (NIV or nasal high flow oxygen) Planned extubation within one hour of inclusion
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación cruzada
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Nonin oximeter with a 90% SpO2 target
During this periods , oxygen will be administered in an manual titration with the FreeO2 device (fixed flow mode) to reach 90% of SpO2. |
Oxygen titration with FreeO2 device (fixed flow mode) to reach the SpO2 target (set at 90%) with Nonin oximeter |
|
Experimental: Philips oximeter with a 90% SpO2 target
During this periods, oxygen will be administered in a manual titration with the FreeO2 device (fixed flow mode), to reach 90% of SpO2. |
Oxygen titration with FreeO2 device (fixed flow mode) to reach the SpO2 target (set at 90%) with Philips oximeter |
|
Experimental: Nonin oximeter with a 94% SpO2 target
During this periods , oxygen will be administered in a manual titration with the FreeO2 device (fixed flow mode) to reach 94% of SpO2. |
Oxygen titration with FreeO2 device (fixed flow mode) to reach the SpO2 target (set at 94%) with Philips oximeter |
|
Experimental: Philips oximeter with a 94% SpO2 target
During this periods, oxygen will be administered in a manual titration with the FreeO2 device (fixed flow mode), to reach 94% of SpO2. |
Oxygen titration with FreeO2 device (fixed flow mode) to reach the SpO2 target (set at 94%) with Philips oximeter |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Oxygen flow (or FiO2)
Periodo de tiempo: Mean Oxygen flow in the two last minute of each study period (between minute 8 and 10)
|
Oxygen flows (or FiO2) at the end of each study period (last minute average) to reach SpO2 target to reach SpO2 target with specific oximeter |
Mean Oxygen flow in the two last minute of each study period (between minute 8 and 10)
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Difference between SpO2 and SaO2
Periodo de tiempo: assessed up to 10 minutes - at the same of the arterial blood gases punction
|
Difference (%) between SpO2 from each oximeter and SaO2 (% of SaO2 overestimation and underestimation for each oximeter) |
assessed up to 10 minutes - at the same of the arterial blood gases punction
|
Otras medidas de resultado
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Mean difference on oxymeter
Periodo de tiempo: assessed up to 10 minutes - at the same of the arterial blood gases punction
|
Mean (±SD) of the gaps between the different oximeters tested |
assessed up to 10 minutes - at the same of the arterial blood gases punction
|
|
Occult hypoxemia
Periodo de tiempo: assessed up to 10 minutes - at the same of the arterial blood gases punction
|
Percentage of occult hypoxemia (SaO2<90% and SpO2>=90%) |
assessed up to 10 minutes - at the same of the arterial blood gases punction
|
|
Occult hyperoxemia
Periodo de tiempo: assessed up to 10 minutes - at the same of the arterial blood gases punction
|
Perrcentage of occult hyperoxemia (SaO2>96% and SpO2<=96%) |
assessed up to 10 minutes - at the same of the arterial blood gases punction
|
|
Partial oxygen weaning
Periodo de tiempo: Mean oxygen flow in the two last minute of each study period (between minute 8 and 10)
|
Rate of partial oxygen weaning (Oxygen flow <=0.5 L/min) |
Mean oxygen flow in the two last minute of each study period (between minute 8 and 10)
|
|
Complete oxygen weaning
Periodo de tiempo: Mean oxygen flow in the two last minute of each study period (between minute 8 and 10)
|
Rate of complete oxygen weaning (Oxygen flow =0 L/min or FiO2 0.21) |
Mean oxygen flow in the two last minute of each study period (between minute 8 and 10)
|
|
Respiratory support escalation
Periodo de tiempo: Mean oxygen flow in the two last minute of each study period (between minute 8 and 10)
|
Indication of initiation of respiratory support escalation (Oxygen flow >6 L/min or FiO2 > 0.60) |
Mean oxygen flow in the two last minute of each study period (between minute 8 and 10)
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 22266
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .